Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Fyodor Biotechnologies: 500 Demo Day Batch 22

464 views

Published on

Fyodor Biotechnologies, Biotech firm specializing in diagnostics for Tropical Diseases

Published in: Technology
  • Be the first to comment

Fyodor Biotechnologies: 500 Demo Day Batch 22

  1. 1. Malaria Diagnosis in Minutes Eddy Agbo Chairman & CEO fyodor@fyodorbio.com www.fyodorbio.com First non-blood test for malaria
  2. 2. 212 M Cases per Year Half-a-million Deaths Impacts High, Medium & Low Income Countries Massive Global Health Problem Impacts Rich & Poor fyodor@fyodorbio.com 9 5
  3. 3. Fever is an early sign of malaria Rapid diagnosis within 48 hours critical 516M Malaria Blood Tests
  4. 4. The UMT on pharmacy shelves Regulatory Approvals granted: Nigeria & Liberia Market Beta-test in Nigeria: 72K sold in pharmacies fyodor@fyodorbio.com
  5. 5. Source: Grand View Research Growth: 4.5% 2022 Malaria Diagnostic Market Size $580M $789M 2015 Future is bright 313M Middle Class
  6. 6. Anne Derrick, MBA EVP & Head of Operations Eddy Agbo, DVM, PhD Chairman/CEO & Founder Victoria Enwemadu, Pharm.D VP, Business Development ID-Lelystad,ID-Lelystad, BVBV
  7. 7. Fyodor Biotechnologies Democratizing Malaria Testing email fyodor@fyodorbio.com phone +1.443.300.6236 website www.fyodorbio.com

×